Grifols | GRFS - Capital Ordinário

Preço das Ações
8.21
Mudança Diária
0.16 1.99%
Mensal
2.24%
Anual
21.45%
Q2 Previsão
7.99




Capital Ordinário Alterar Data
Alaunos Therapeutics USD 2.21M 131K 2025-09
Arca Biopharma USD 48.72M 338K 2025-12
aTyr Pharma USD 16.65M 81.34M 2025-12
Bio Path USD 9.24M 934K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 2K 2025-12
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cara Therapeutics USD 9.38M 9.38M 2025-09
Esperion Therapeutics USD 245.22M 39.79M 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Immunic USD 8K 4K 2024-06
Infinity Pharmaceuticals USD 90K 1000 2023-06
Minerva Neurosciences USD 1000 0 2024-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
TherapeuticsMD USD 11K 0 2023-09